R
Ramneek Kaur
Researcher at University of Sydney
Publications - 10
Citations - 54
Ramneek Kaur is an academic researcher from University of Sydney. The author has contributed to research in topics: Drug delivery & Cytotoxicity. The author has an hindex of 3, co-authored 10 publications receiving 29 citations. Previous affiliations of Ramneek Kaur include Jaypee Institute of Information Technology.
Papers
More filters
Journal ArticleDOI
Synthesis, characterization and evaluation of antioxidant properties of catechin hydrate nanoparticles
TL;DR: In this article, a targeted nanoparticle-based carrier system for catechin hydrate (CH) is proposed, which is an important phyto compound, reported to have potential therapeutic activity for prevention and treatment of various central nervous system disorders.
Journal ArticleDOI
Bio Pharmaceutics Classification System (BCS) Class IV Drug Nanoparticles: Quantum Leap to Improve Their Therapeutic Index.
TL;DR: The optimized HCTZ nano coacervates may prove to be a suitable potential option for effective delivery of BCS class IV drugs.
Journal ArticleDOI
Synthesis and Characterization of Citrus limonum Essential Oil Based Nanoemulsion and Its Enhanced Antioxidant Activity with Stability for Transdermal Application
TL;DR: In this article, a nano-emulsion system (LO-NE) was proposed for anti-oxidant properties of lemons oil with high stability and anti-fungal properties using aqueous titration method.
Book ChapterDOI
The Aging Brain: From Physiology to Neurodegeneration
TL;DR: The following chapter discusses the structural and functional alterations in the brain in ageing and neurodegeneration.
Journal ArticleDOI
In-Silico Validation and Development of Chlorogenic Acid (CGA) Loaded Polymeric Nanoparticle for Targeting Neurodegenerative Disorders
Vinayak Agarwal,Shriya Agarwal,Ramneek Kaur,Pranav Pancham,Harleen Kaur,Siddhi Bhardwaj,Manisha Singh +6 more
TL;DR: In-silico validation of CGA as an effective therapeutic agent targeting various NDDs followed by the fabrication of polymeric nanoparticles-based carrier system to overcome its pharmacological limitations and improve its stability is aimed at.